Latest: Tata Chemicals Q1 FY27 (Apr–Jun 2026) results →This page is Q3 FY26 (Oct–Dec 2025).All Q3 FY26 results →
TC

Tata Chemicals

Q3 FY26Chemicals & Petrochemicals

Tata Chemicals Q3 FY26 earnings call: Revenue & Margins

Q3 FY26 earnings call: what management said on revenue, margins and capex.

Price₹626
Market cap₹16.0K Cr
Updated26 Aug 2026
Read4 min read

Get Tata Chemicals's next results in your feed

The short version

Tata Chemicals expects medium-term modest growth in soda ash demand, driven by solar glass and stable consumption in other applications. - India shows relatively robust demand growth, with ongoing capacity expansions in salt, silica, and soda ash focused on premium and higher-margin products. - The U.K. Tata Chemicals expects to achieve guided EBITDA of INR 250 crores for FY26, targeting a quarterly EBITDA run rate of about INR 60-65 crores with positive PAT, though currently behind schedule by six months due to operational disruptions.

From Tata Chemicals's Q3 FY26 earnings-call transcript · updated 26 Aug 2026.

Revenue & Sales Performance

  • Tata Chemicals expects medium-term modest growth in soda ash demand, driven by solar glass and stable consumption in other applications.
  • India shows relatively robust demand growth, with ongoing capacity expansions in salt, silica, and soda ash focused on premium and higher-margin products.
  • The U.K. pharmaceutical salt unit is increasing capacity utilization, contributing to future revenue.
  • Kenya’s new 50,000-tonne electric calciner soda ash plant will boost higher-margin volume from Q4 FY26.
  • Novabay Singapore acquisition expands presence in the Asian premium bi-carb market, supporting growth.
  • Indian salt capacity expansion of 210 KT per annum with INR 515 crore investment is underway to meet growing demand.

2 more points from Tata Chemicals's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Tata Chemicals said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Approved INR 515 crore for a greenfield iodized salt facility in India with 210 KT capacity.
  • INR 775 crore for 50 KT precipitated silica expansion at Cuddalore, India.
  • INR 135 crore for 350 KT dense ash plant reconfiguration in Mithapur, India.
  • Valinokkam facility in Tamil Nadu expected commissioning over next 36 months.
  • Kenya: Additional 50 KT electric calciner soda ash plant operational by March 2026.
  • Novabay Singapore acquisition to expand premium bi-carb market in Asia, with potential to double capacity from 60 KT to 120 KT.
  • Focus on low CAPEX, high-return capacities, mainly in India.

2 more points from Tata Chemicals's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
2Yasho Industries
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Tata Chemicals said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Tata Chemicals said on order book & pipeline — free account, 30 seconds.

Tata Chemicals — Quarterly revenue & net profit

Revenue Net profit Net loss
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Tata Chemicals Q3 FY26 results — key figures

Tata Chemicals Q3 FY26 reported results vs Q3 FY25, ₹ crore
₹ CrQ3 FY26Q3 FY25YoYQ2 FY26QoQ
Revenue3,5503,590-1.1%3,877-8.4%
Operating profit (EBITDA)345434-20.5%537-35.8%
Operating margin10%12%-2 pp14%-4 pp
Profit before tax-73-4—236-130.9%
Net profit (PAT)-69-21—154-144.8%
EPS (₹)-3.65-2.08—3.02-220.9%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹3.4K Cr, net loss ₹2.1K Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Neochem Bio (Q3 FY26)

    Revenue for Q2 FY26 (Sept’25) stood at ₹4,583.16 Lakh. Key investor presentation takeaways from Neochem Bio Solutions Ltd's Q3 FY26 investor presentation — and

  • Thirumalai Chemicals (Q3 FY26)

    Q3 FY26 Revenue from Operations (INR Cr):** . Key investor presentation takeaways from Thirumalai Chemicals Ltd's Q3 FY26 investor presentation — and how it ran

  • IVP (Q3 FY26)

    Q3 FY26 Revenue from Operations: ₹144.97 crore . Key investor presentation takeaways from IVP's Q3 FY26 investor presentation — and how it ranks against sector

  • Gujarat Alkalies (Q3 FY26)

    3,144.48 Crores, down from Rs. Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY26 investor presentation — and how it ranks agai

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Tata Chemicals and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Tata Chemicals Q3 FY26 results?

Tata Chemicals expects medium-term modest growth in soda ash demand, driven by solar glass and stable consumption in other applications. - India shows relatively robust demand growth, with ongoing capacity expansions in salt, silica, and soda ash focused on premium and higher-margin products. - The U.K. Tata Chemicals expects to achieve guided EBITDA of INR 250 crores for FY26, targeting a quarterly EBITDA run rate of about INR 60-65 crores with positive PAT, though currently behind schedule by six months due to operational disruptions.

What is Tata Chemicals share price analysis?

Tata Chemicals currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹15,967 Cr. Investors should review the full earnings analysis for detailed insights.

Is Tata Chemicals planning capital expenditure?

Approved INR 515 crore for a greenfield iodized salt facility in India with 210 KT capacity.

Keep Tata Chemicals on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.